← Back to all trials
Not Yet Recruiting
NCT07643467
Fluorescent Probe for Assessment of Renal Elimination
Conditions: Augmented Renal Clearance, Critical Illness
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 200
Sponsor: Aaron Cook
Location: UKHealthCare/University of Kentucky Lexington Kentucky
Summary
Accurate measures of kidney function is important for precision dosing of many medications. The current methods of determining kidney function largely hinge on the use of equations that use common laboratory values such as serum creatinine \& static variables like age \& weight. These are helpful for trending over time, but often are inaccurate during times of medical illness. Other more accurate methods of measuring kidney function include urine collection, although this is not commonly used because of various reasons that make the collection inconvenient or unreliable. The new transdermal glomerular filtration (tGFR) device permits accurate, real-time evaluation of kidney function. This novel method has not been rigorously compared with urine collection \& other methods of determining kidney function in hospitalized patients. The goal of the study is to compare tGFR with other accepted methods of determining kidney function.
Eligibility Criteria
Inclusion Criteria:
* 18-65 years old
* critically ill or acutely ill hospitalized patients admitted to the intensive care unit
* Stable/normal renal function
Exclusion Criteria:
* Prisoners
* Pregnant women
* Laboratory evidence of unstable kidney function (KDIGO AKI stage 1-3--This includes subjects with Scr \> 1.5x baseline)
Source: ClinicalTrials.gov (NCT07643467). StuddyBuddy aggregates publicly available trial information.